These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 25684224)

  • 1. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
    Werhahn KJ; Trinka E; Dobesberger J; Unterberger I; Baum P; Deckert-Schmitz M; Kniess T; Schmitz B; Bernedo V; Ruckes C; Ehrlich A; Krämer G
    Epilepsia; 2015 Mar; 56(3):450-9. PubMed ID: 25684224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
    Lattanzi S; Trinka E; Del Giovane C; Nardone R; Silvestrini M; Brigo F
    Epilepsia; 2019 Nov; 60(11):2245-2254. PubMed ID: 31608438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis.
    Brigo F; Lattanzi S; Zelano J; Bragazzi NL; Belcastro V; Nardone R; Trinka E
    Seizure; 2018 Oct; 61():57-62. PubMed ID: 30096625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness at 24 Months of Single-Source Generic Carbamazepine, Lamotrigine, or Levetiracetam in Newly Diagnosed Focal Epilepsy.
    Gurbani S; Chayasirisobhon S; Gurbani A; Tovar S; Pietzsch E; Spurgeon B
    Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
    Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
    Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy.
    Eun SH; Eun BL; Lee JS; Hwang YS; Kim KJ; Lee YM; Lee IG; Lee M; Ko TS; Kim JT; Eom S; Kim HD
    Brain Dev; 2012 Nov; 34(10):818-23. PubMed ID: 22521904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC; Baker G
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.